CSL, GSK and Sanofi
Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply
The companies will use the funds to fill vials and pre-filled syringes with stockpiled vaccine ingredients, aimed at raising the country’s total supply of ready-to-use doses to 10 million within the f
GSK, Sanofi, CSL said to win $72M U.S. bird flu vaccine contract (update)
Sanofi (NASDAQ:SNY), and CSL (OTCQX:CSLLY) to expand the production of bird flu vaccines amid an ongoing outbreak among poultry and livestock that has led to fears of a potential human-to-human transmission of the virus.
US provides $72M to vaccine manufacturers to advance bird flu shot preparedness
There are currently no recommendations for anyone to be vaccinated against bird flu and federal health officials note this is being done out of "an abundance of caution."
GSK, Sanofi, CSL nab $72M in BARDA funding to boost bird flu vaccine supply
CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the country’s supply of bird flu vaccines. | CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.
GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report
The U.S. government has granted $72 million to European pharma giants GSK Plc (NYSE:GSK), Sanofi SA (NASDAQ:SNY) and Australian firm CSL Limited (OTC:CSLLY) to more than double the U.S. supply of bird flu vaccines.
The US Is Loading Up on Bird Flu Vaccine
As more farm workers get sick with avian influenza, the US federal government is putting $72 million toward strengthening its vaccine stockpile.
U.S. Boosts Bird Flu Vaccine Production with $72M Funding
The U.S. government has allocated $72 million to GSK, Sanofi, and CSL Ltd to enhance bird flu vaccine production amid a notable outbreak affecting 14 states. The funding aims to double the country's supply of bird flu vaccines to 10 million doses by early 2025.
BAR­DA doles out $72M to Sanofi, GSK and CSL for bird flu vac­cine sup­ply
The Center for Biomedical Advanced Research and Development Authority (BARDA) is giving $72 million to three drugmakers to help fortify the US supply of bird flu vaccine ahead of 2025. The funding was disclosed by the Administration for Strategic Preparedness and Response,
US allocates $72M to CSL, GSK, Sanofi for bird flu vaccine production
US has announced team up with multinational pharmaceutical companies CSL, GSK, Sanofi, and Seqirus for a $72 million worth of bird flu vaccine production initiative.On Friday, October 4, the US Federal health officials announced that they will
Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply, Bloomberg News reports
GSK, Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, Bloomberg News reported on Friday. The move comes as a multi-state outbreak among livestock and poultry has caused several human infections,
devdiscourse1d
Health Headlines Unveiled: Bird Flu, Assisted Dying Bill, and More
Current health highlights include Sanofi, GSK, and CSL expanding bird flu vaccine efforts in the U.S. following a multi-state ...
Sanofi gets two bids valuing its consumer health unit at about $17 billion, Bloomberg News reports
Sanofi has received two separate bids for its consumer health unit, which could be valued at 15 billion euros ($16.74 billion ...
US to double emergency bird flu vaccines as more people, herds become infected
Federal officials plan to double the stockpile of emergency bird flu vaccines as they identify more people infected with the ...